Toronto-Dominion Bank »

Black Diamond Therapeutics shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2026-06-30 $396k 214k 1.85

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
eBay (EBAY)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Rbc Cad (RY)
Intel Corporation (INTC)
Micron Technology (MU)
Cibc Cad (CM)
Alphabet Cap Stk Cl A (GOOGL)
Sandisk Corp (SNDK)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)

View all positions for Toronto-Dominion Bank

Top funds holding Black Diamond Therapeutics

NEA Management Company
BlackRock
Acadian Asset Management
Vanguard Capital Management
Renaissance Technologies
Defilade Capital Management
Dimensional Fund Advisors
Geode Capital Management
Connor, Clark & Lunn Investment Management
AWM Investment Company
Marshall Wace
Bridgeway Capital Management
FMR
Balyasny Asset Management
Bank of America Corporation

View all funds holding Black Diamond Therapeutics